Characteristics and outcome of octogenarian versus young patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) treated with ketoconazole.

被引：0
|
作者：
Sinibaldi, Victoria J.
Dadon-Nachum, Michal
Gottfried, Maya
Maimon, Natalie
Dovrish, Zamir
Peer, Avivit
Neumann, Avivit
Sella, Avishay
Kovel, Svetlana
Carducci, Michael Anthony
Eisenberger, Mario A.
Kejzman, Daniel
机构：
[1] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[2] Meir Med Ctr, Dept Oncol, Kefar Sava, Israel
[3] Meir Med Ctr, Lung Canc Unit, Kefar Sava, Israel
[4] Tel Aviv Univ, Sackler Sch Med, Meir Med Ctr, Genitourinary Oncol Serv,Div Oncol, Kefar Sava, Israel
[5] Meir Med Ctr, Dept Internal Med D, Kefar Sava, Israel
[6] Rambam Hlth Care Campus, Haifa, Israel
[7] Rambam Med Ctr, Dept Oncol, Haifa, Israel
[8] Assaf Harofeh Med Ctr, IL-70300 Zerifin, Israel
[9] Asaf Harofe Med Ctr, Dept Oncol, Zerifin, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 04期
关键词：
D O I：
10.1200/jco.2014.32.4_suppl.256
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
256
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Prognostic factors for patients with metastatic castrate-resistant prostate cancer (mCRPC) receiving abiraterone acetate prechemotherapy.
    Charnley, Natalie
    Birtle, Alison J.
    Swindell, Ric
    Parikh, Omi
    Wise, Marcus
    Kumar, Varadarajan
    Danwata, Falalu Dahiru
    Thompson, Catherine
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [22] Costs of skeletal-related events (SREs) in patients with metastatic castrate-resistant prostate cancer (mCRPC) treated with oral therapies.
    Engel-Nitz, Nicole
    Behl, Ajay S.
    Blauer-Peterson, Cori
    Li, Sophia S.
    Dawson, Nancy Ann
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [23] Phase 2 study (AARDVARC) of AZD4635 in combination with durvalumab and cabazitaxel in patients (pts) with progressive metastatic castrate-resistant prostate cancer (mCRPC).
    Gordoa, Teresa Alonso
    Goodman, Michael Moses
    Vulsteke, Christof
    Roubaud, Guilhem
    Zhang, Jingsong
    Parikh, Mamta
    Piulats, Josep M.
    Azaro, Analia
    James, Gareth D.
    Cavazzina, Riccardo
    Gangl, Eric
    Thompson, Jeff
    Pouliot, Gayle Pageau
    Kumar, Rakesh
    Sweeney, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [24] Abiraterone for the Treatment of Metastatic Castrate-Resistant Prostate Cancer
    Beckett, Robert D.
    Rodeffer, Kathryn M.
    Snodgrass, Rachel
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (7-8) : 1016 - 1024
  • [25] Treatment sequencing in metastatic castrate-resistant prostate cancer
    Sartor, Oliver
    Gillessen, Silke
    ASIAN JOURNAL OF ANDROLOGY, 2014, 16 (03) : 426 - 431
  • [26] Phase I study of apalutamide (ARN) plus abiraterone acetate (AA), docetaxel (D) in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC)
    Molina, A. M.
    Christos, P. J.
    Whang, Y.
    Nordquist, L.
    Hackett, A. L.
    Beltran, H.
    Faltas, B.
    Nanus, D.
    Giannakakou, P.
    Tagawa, S. T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [27] Keynote-365 cohort a: Pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC).
    Yu, Evan Y.
    Massard, Christophe
    Retz, Margitta
    Tafreshi, Ali
    Carles Galceran, Joan
    Hammerer, Peter
    Fong, Peter C. C.
    Shore, Neal D.
    Joshua, Anthony
    Linch, Mark David
    Gurney, Howard
    Romano, Emanuela
    Augustin, Marinela
    Piulats, Josep M.
    Wu, Haiyan
    Schloss, Charles
    Poehlein, Christian Heinrich
    De Bono, Johann S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [28] Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer
    Francini, Edoardo
    Fiaschi, Anna Ida
    Petrioli, Roberto
    Francini, Filippo
    Bianco, Vincenzo
    Perrella, Armando
    Paganini, Giovanni
    Laera, Letizia
    Roviello, Giandomenico
    ANTI-CANCER DRUGS, 2014, 25 (04) : 472 - 477
  • [29] ASSOCIATION OF SARCOPENIA VERSUS OBESITY WITH SURVIVAL IN METASTATIC OR CASTRATE-RESISTANT PROSTATE CANCER
    Huelster, Heather
    Xu, Mark
    Hatcher, Jeremy
    Avulova, Svetlana
    Glaser, Zachary
    Moses, Kelvin
    JOURNAL OF UROLOGY, 2020, 203 : E562 - E562
  • [30] Comparison of survival of African-American (AA) patients (pts) in docetaxel (D)-based combination therapies in metastatic castrate-resistant prostate cancer (mCRPC).
    Karzai, Fatima
    Madan, Ravi Amrit
    Ning, Yang-Min
    Theoret, Marc Robert
    Arlen, Philip M.
    Parnes, Howard L.
    Ojemuyiwa, Michelle A.
    Strauss, Julius
    Dawson, Nancy Ann
    McLeod, David G.
    Harold, Nancy
    Couvillon, Anna
    Cordes, Lisa M.
    Chen, Clara
    Steinberg, Seth M.
    Sissung, Tristan M.
    Price, Douglas K.
    Gulley, James L.
    Figg, William Douglas
    Dahut, William L.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
12345